DexCom Inc. (DXCM)

142.73
0.92 0.65
NASDAQ : Health Technology
Prev Close 141.81
Open 143.43
Day Low/High 139.24 / 145.99
52 Wk Low/High 50.09 / 152.14
Volume 1.38M
Avg Volume 1.13M
Exchange NASDAQ
Shares Outstanding 88.84M
Market Cap 13.28B
EPS -0.60
P/E Ratio 311.38
Div & Yield N.A. (N.A)

Latest News

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Tech Doesn't Have Good Defense: Cramer's 'Mad Money' Recap (Thursday 9/6/18)

Jim Cramer, celebrating the opening of the NFL season, says this is just another day of total tech mayhem.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

Dexcom G6® Continuous Glucose Monitoring System Will Be Available To Medicare Beneficiaries With Diabetes In Early 2019

Dexcom G6® Continuous Glucose Monitoring System Will Be Available To Medicare Beneficiaries With Diabetes In Early 2019

DexCom, Inc. ( NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the new Dexcom G6 ® CGM System will be covered for Medicare beneficiaries, having met the category requirements for therapeutic CGM systems by the U.

DexCom Schedules Third Quarter 2018 Earnings Release And Conference Call For November 6, 2018 At 4:30 P.m. Eastern Time.

DexCom Schedules Third Quarter 2018 Earnings Release And Conference Call For November 6, 2018 At 4:30 P.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2018 financial results after market close on Tuesday, November 6, 2018.

Dexcom Acquires TypeZero Technologies

Dexcom Acquires TypeZero Technologies

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that it has acquired TypeZero Technologies, Inc.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Quentin Blackford, Executive Vice President and Chief Financial Officer, and Matthew Dolan, Vice President,...

DexCom Executive Chairman And Director Terry Gregg Retires

DexCom Executive Chairman And Director Terry Gregg Retires

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today that Terry Gregg has retired as the Company's Executive Chairman and from the Company's Board of Directors after 13 years with Dexcom.

DexCom Reports Second Quarter 2018 Financial Results

DexCom Reports Second Quarter 2018 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2018.

Weekly Roundup

An earnings heavy week also included progress on reducing trade tensions.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Quentin Blackford, Executive Vice...

The Three Bullish Charts of DexCom

The Three Bullish Charts of DexCom

With more gains likely on the charts let's come up with a strategy to take advantage of this opportunity.

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Market Loves Fintech: Cramer's 'Mad Money' Recap (Thursday 7/19/18)

Jim Cramer says financial payment companies are the most beloved in the market right now. He explains digitized payment companies. And love.

Top Analysts Say Gamble On These 3 Ace Stocks

Top Analysts Say Gamble On These 3 Ace Stocks

We've got a 'cheat sheet' for you. Here are the best names that have analysts cheering.

DexCom Schedules Second Quarter 2018 Earnings Release And Conference Call For August 1, 2018 At 4:30 P.m. Eastern Time.

DexCom Schedules Second Quarter 2018 Earnings Release And Conference Call For August 1, 2018 At 4:30 P.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2018 financial results after market close on Wednesday, August 1, 2018.

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Industrials in Value Territory: Cramer's 'Mad Money' Recap (Thursday 6/21/18)

Jim Cramer says many stocks already reflect the worst-case scenarios, and that means he sees a lot of upside potential.

DocuSign, DexCom, Skechers USA: 'Mad Money' Lightning Round

DocuSign, DexCom, Skechers USA: 'Mad Money' Lightning Round

Jim Cramer weighs in on DocuSign, DexCom, Skechers USA, Campbell Soup, Evolus, Zscaler, Lockheed Martin and more.

Revaluing Entertainment Companies: Cramer's 'Mad Money' Recap (Thursday 6/14/18)

Revaluing Entertainment Companies: Cramer's 'Mad Money' Recap (Thursday 6/14/18)

Jim Cramer says there's the market that's about entertainment and anything that delivers entertainment to you. And then there's everything else.

Dexcom G6® CGM System Receives CE Mark

Dexcom G6® CGM System Receives CE Mark

Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up.

Dexcom G5 Continuous Glucose Monitoring System Now Available On Mobile, Smart Devices For Medicare Patients With Diabetes

Dexcom G5 Continuous Glucose Monitoring System Now Available On Mobile, Smart Devices For Medicare Patients With Diabetes

Dexcom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring for people with diabetes, announced today the U.

DexCom Announces Upcoming Conference Presentation

DexCom Announces Upcoming Conference Presentation

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate Development, and Matthew Dolan, Vice President...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CRL, DXCM, EVTC, GEC, KRC, WRLD, WWW Downgrades: ACIW, DHT, MDP, PPC, SPKE, SUN, SYMC Initiations: AYX, CLPR, EGC Read on to get TheStreet Quant Ratings' detailed report:

DexCom Reports First Quarter 2018 Financial Results

DexCom Reports First Quarter 2018 Financial Results

DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2018.

DexCom Schedules First Quarter 2018 Earnings Release And Conference Call For May 2, 2018 At 4:30 P.m. Eastern Time.

DexCom Schedules First Quarter 2018 Earnings Release And Conference Call For May 2, 2018 At 4:30 P.m. Eastern Time.

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2018 financial results after market close on Wednesday, May 2, 2018.

PayPal, Advanced Micro Devices, Intel: 'Mad Money' Lightning Round

PayPal, Advanced Micro Devices, Intel: 'Mad Money' Lightning Round

Jim Cramer highlights PayPal, Advanced Micro Devices, Intel, Nvidia, DexCom and CVS Health.

FANG Stocks Strike Back: Cramer's 'Mad Money' Recap (Thursday 3/29/18)

FANG Stocks Strike Back: Cramer's 'Mad Money' Recap (Thursday 3/29/18)

Jim Cramer says if you can't handle the newsflow, both real and fake, you may need to use this rally to lighten up. But if you can, then hold on, stick around and make money.

FDA Authorizes Marketing Of The New Dexcom G6® CGM Eliminating Need For Fingerstick Blood Testing For People With Diabetes

FDA Authorizes Marketing Of The New Dexcom G6® CGM Eliminating Need For Fingerstick Blood Testing For People With Diabetes

DexCom, Inc. ( NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) is pleased to announce that the U.

TheStreet Quant Rating: C- (Hold)